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CT for Large Transcatheter Implants
Robert J. Lederman, MD,* Marcus Y. Chen, MD,* Toby Rogers, MD,* Dee Dee Wang, MD,y Gaetano Paone, MD,y
Mayra Guerrero, MD,y William W. O’Neill, MD,y Adam B. Greenbaum, MDy
TRANSCAVAL (“CAVAL-AORTIC”) ACCESS IS A NEW APPROACH TO INTRODUCE LARGE DEVICES, SUCH AS
transcatheter aortic valves, into the abdominal aorta in patients who otherwise lack access options. In
this technique, coaxial catheters are introduced into the body from the femoral vein, and advanced into
the abdominal aorta from the adjoining inferior vena cava under ﬂuoroscopic guidance. The aorto-caval
ﬁstula is closed using a nitinol cardiac occluder device after the therapeutic procedure (1). AfterTABLE 1 Classiﬁcation of Favorability Recommendations
Favorable All of the following:
 A clear access point in the aorta from the neighboring cava
 #8-mm away lateral distance between aorta and caval lumens
 Calciﬁcation grade 0 to 2
 No important interposed structures (hemiazygos or lumbar plexus veins OK; lumbar artery not OK; solitary renal vein not OK)
 Centerline distance from femoral vein puncture site to aortic entry at least 7 cm less than the working length of the required
introducer sheath.
 No aortic aneurysm, severe ectasia, atherosclerosis, or thrombus at proposed entry site
 Target is >10 mm below lowest renal artery and >10 mm above aortic bifurcation
Feasible Any of the following:
 Caval-aortic lumen distance 8 to 12 mm at proposed target
 Aortic aneurysm, severe ectasia, atherosclerosis, or thrombus at proposed entry site
 Centerline distance from femoral vein puncture site to aortic entry 5 to 7 cm less than the working length of the required
introducer sheath.
 Planned on noncontrast CT
Unfavorable Any of the following:
 Calciﬁcation grade 3
 Centerline distance from femoral vein puncture site to aortic entry is 5 cm less than the working length of the required
introducer sheath
 Caval-aortic lumen distance >12 mm at proposed target
 Target is <10 mm below lowest renal artery or <10 mm above aortic bifurcation
 Leftward aortic angulation approximately >20
 Other high risk features (e.g., permanent IVC ﬁlter, threatens 2/3 of mesenteric arteries, and so on)
CT ¼ computed tomography.
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FIGURE 1 Finding Potential Crossing Targets
Using CT analysis software, isolate (segment) aortoiliac arteries and inferior vena cava ([IVC] from the level of the renal arteries to the femoral bifurcation) and ﬁnd a
calcium-free “target window” (wider than the proposed introducer sheath) on the right wall of the aorta close to the IVC. Heavily calciﬁc targets are difﬁcult to cross and
may increase the risk of complications. Mark the proposed target with an arrow on a multiplanar computed tomography reconstruction. Rotate the coronal plane (A)
obliquely to include the centers of the aorta and cava in axial and sagittal sections (B and C) at the proposed target. Generate volume-rendered images of the segmented
aorta and cava (D) by coloring the aorta red, calcium white, cava blue with 30% transparency, and lumbar spine grayscale with 90% transparency for bony context.
Manually ensure that arterial segmentation includes “deep” or adventitial aortic calciﬁcation and includes all left renal veins. Cut away all visceral arteries (beyond a 1-cm
stump) and organs.
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1168systematic image analysis (Figures 1 to 6), we provide favorability recommendations. “Unfavorable” in-
dicates that transcaval access is not recommended. “Feasible” suggests elevated risk over a favorable
classiﬁcation (Table 1).FIGURE 2 Reﬁne the Proposed
Crossing Target Using an En-Face
Hemi-Aorta View
The en-face view (A, Online Video 1)
depicts calcium-free windows on the
right aortic wall as seen from the cava.
Isolate the right half of the aorta to
depict mural aortic calcium (B, C) by
slicing away the entire left half (C).
FIGURE 3 Further Reﬁne the Proposed Target to Avoid Hazards
The target should not be far from the cava (A), but should be sufﬁciently far from the right renal arteries, left renal veins, and the aortoiliac bifurcation (>10 mm)
to avoid closure device encroachment (see Figure 4D). Retroaortic veins (B, white arrow and blue dotted line) should be identiﬁed and avoided. There should be
no important interposed structures, such as the bowel (C). More often, the bowel is “draped” across the cava and aorta (D), and this requires the operator to aim
posteriorly. Aortic aneurysm (E) and atheroma (F) do not disqualify crossing; pouch-shaped targets (yellow and red arrows, respectively) appear to seat closure
devices well. However, intraluminal aortic pathology cephalad to the crossing target, such as aortic aneurysm/thrombus, atheroma, or dissection, may constitute
hazardous sheath trajectories. Lumbar artery ostia should be avoided. However, lumbar venous plexus structures are redundant and should not disqualify a
transcaval trajectory. Ao ¼ aorta.
FIGURE 4 Obtain Key Measurements
(A) The lumen-to-lumen distance between the aorta and inferior vena cava at the
target is measured horizontally (and includes the interposed aortic atheroma
or thrombus). The commercially available nitinol occluder devices have a neck
length of 7 to 8 mm. Tracts >8 to 12 mm may be less favorable and distances
>12 mm are unfavorable for transcaval procedures using currently available
occluder devices. (B) The recommended working ﬂuoroscopic projection angles
for crossing and corresponding orthogonal projection for pointing at the aortic
snare are shown. The angle is measured between the cava and aortic centers
while the patient is lying ﬂat. (C) The diameter of the inferior vena cava and aorta
at the target is shown. This is measured along the line connecting the cava and
aortic centers and is used to choose a suitable caval-guiding catheter and an
oversized snare device that will seat properly to create a bull’s-eye target during
transcaval crossing. (D) The lumbar spine landmark corresponding to the pro-
posed crossing target is shown. Depict these landmarks in a coronal oblique view
at the recommended projection angle and in a straight sagittal view. We report a
semiquantitative location score, where the mid-body of the third lumbar
vertebra is called L3.0, and the middle of the intervertebral disk between L3 and
L4 is called L3.5. We identify bailout options including the diameter of the aorta
above and below the target (typically  3 cm), and the “best” iliofemoral artery
side to be used in case emergency endograft therapy is required. These mea-
surements inform the choice of endograft device. The distance of the proposed
target from the right renal artery and the top of the aorto-iliac bifurcation is
shown. This helps the operator ensure the closure device will not interfere with
either vascular structure. The trajectory distance from the femoral vein skin
puncture into the aortic target must be signiﬁcantly less (by approximately 7 cm)
than the working length of the selected introducer sheath, even in obese
patients. LAO ¼ left anterior oblique; RAO ¼ right anterior oblique.
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FIGURE 5 Classifying the Aortic
Calciﬁcation Pattern
We use the following grades: 0 ¼ no
calcium; 1 ¼ scattered calcium that is not
conﬂuent (A); 2 ¼ multifocal calciﬁcation
having a calcium-spared “window” at a
proposed crossing target (B); 3 ¼ “porce-
lain” abdominal aorta, which at present
we consider a contraindication for this
procedure (C).
FIGURE 6 Roadmap Images to Be Posted
in the Procedure Room
To help guide operators, post roadmap im-
ages (A to F) in the procedure room. (A)
Axial thin slice at the crossing target. (B to
D) Oblique-coronal views (rotated to match
the recommended ﬂuoroscopy projection
angle, such as right anterior oblique 30) at
the crossing target. Supply 3 snapshots as
follows: (B) thin to highlight the ideal
crossing target; (C) as thick as the aorta, to
convey a maximum intensity projection of
the entire aortic calcium pattern; (D) thick-
est to depict aortic calciﬁcation in the
context of the vertebral spine, to mimic the
expected ﬂuoroscopy pattern during the
procedure. These are critical ﬁducial de-
pictions of the target during crossing.
(E) Sagittal thin and/or thick slice along the
vertebral column to indicate the crossing
target. (F) The en-face hemi-aorta view to
depict the calcium-spared window on the
aorta (yellow dot).
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